Education
About Us
Working with TipRanks
Follow Us
National Health Investors (NHI)
NYSE:NHI
RESEARCH TOOLSreports
Total Valuation
National Health Investors has a market cap or net worth of $3.38B. The enterprise value is $3.37B.
Market Cap$3.38B
Enterprise Value$3.37B
Share Statistics
National Health Investors has 46,693,672 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,693,672
Owned by Insiders4.66%
Owned by Institutions8.91%
Financial Efficiency
National Health Investors’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.45%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.45%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee11.17M
Profits Per Employee4.55M
Employee Count30
Asset Turnover0.13
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of National Health Investors is 22.02. National Health Investors’s PEG ratio is 19.11.
PE Ratio22.02
PS Ratio0.00
PB Ratio2.41
Price to Fair Value2.22
Price to FCF16.85
Price to Operating Cash Flow16.09
PEG Ratio19.11
Income Statement
In the last 12 months, National Health Investors had revenue of 335.18M and earned 137.99M in profits. Earnings per share was 3.14.
Revenue335.18M
Gross Profit324.02M
Operating Income183.86M
Pretax Income136.59M
Net Income137.99M
EBITDA264.16M
Earnings Per Share (EPS)3.14
Cash Flow
In the last 12 months, operating cash flow was 213.42M and capital expenditures -3.39M, giving a free cash flow of 209.35M billion.
Operating Cash Flow213.42M
Free Cash Flow209.35M
Free Cash Flow per Share4.48
Dividends & Yields
National Health Investors pays an annual dividend of $0.899, resulting in a dividend yield of 4.97%
Dividend Per Share$0.899
Dividend Yield4.97%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.45
52-Week Price Change17.53%
50-Day Moving Average74.17
200-Day Moving Average73.48
Relative Strength Index (RSI)40.58
Average Volume (3m)223.95K
Important Dates
National Health Investors upcoming earnings date is Aug 11, 2025, TBA Not Confirmed.
Last Earnings DateMay 5, 2025
Next Earnings DateAug 11, 2025
Ex-Dividend DateJun 30, 2025
Financial Position
National Health Investors as a current ratio of 92.80, with Debt / Equity ratio of 0.00%
Current Ratio92.80
Quick Ratio92.80
Debt to Market Cap0.38
Net Debt to EBITDA4.25
Interest Coverage Ratio3.38
Taxes
In the past 12 months, National Health Investors has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate>-0.01
Enterprise Valuation
National Health Investors EV to EBITDA ratio is 15.77, with an EV/FCF ratio of 20.42.
EV to Sales12.41
EV to EBITDA15.77
EV to Free Cash Flow20.42
EV to Operating Cash Flow20.02
Balance Sheet
National Health Investors has $135.00M in cash and marketable securities with $1.26B in debt, giving a net cash position of $1.13B billion.
Cash & Marketable Securities$135.00M
Total Debt$1.26B
Net Cash$1.13B
Net Cash Per Share$24.16
Tangible Book Value Per Share$31.59
Margins
Gross margin is 88.53%, with operating margin of 56.55%, and net profit margin of 41.17%.
Gross Margin88.53%
Operating Margin56.55%
Pretax Margin40.77%
Net Profit Margin41.17%
EBITDA Margin78.73%
EBIT Margin57.50%
Analyst Forecast
The average price target for National Health Investors is $83.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$83.25
Price Target Upside13.36% Upside
Analyst ConsensusModerate Buy
Analyst Count5
Revenue Growth Forecast7.44%
EPS Growth Forecast4.23%